Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gliosarcomas: analysis of 11 cases do two subtypes exist?

Maurizio Salvati1, Emanuela Caroli, Antonino Raco

  • 1Department of Neurological Sciences - Neurosurgery, INM Neuromed IRCCS, Pozzilli (Is), Italy.

Journal of Neuro-Oncology
|August 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overexpression of the Ubiquitin Ligase RNF182 Is Associated with High-Grade Gliomas.

Cancers·2026
Same author

Safety of Acetylsalicylic Acid Continuation in Mono- and Multi-Level Lateral Lumbar Interbody Fusion: Multicenter Comparative Study on 332 Patients.

Global spine journal·2025
Same author

Stand-Alone Lateral Lumbar Interbody Fusion at L3-L4 with 3D-Printed Porous Titanium Cages: A Safe and Effective Alternative in the Treatment of Degenerative Disc Disease (DDD).

Journal of clinical medicine·2025
Same author

Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study.

Neurosurgical review·2025
Same author

MicroRNAs Expression Profile in MN1-Altered Astroblastoma.

Biomedicines·2025
Same author

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.

Acta neuropathologica communications·2024

Gliosarcoma treatment outcomes vary. A multidisciplinary approach combining surgery, radiotherapy, and chemotherapy may offer slightly prolonged survival for patients with gliosarcoma, despite the poor prognosis.

Area of Science:

  • Neuro-oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Conflicting reports exist regarding the clinical behavior and optimal management of gliosarcomas.
  • Gliosarcomas are rare brain tumors with both glial and sarcomatous components, presenting diagnostic and therapeutic challenges.

Purpose of the Study:

  • To investigate the clinical, radiological, surgical, and therapeutic aspects of gliosarcoma.
  • To evaluate the impact of tumor component prevalence and treatment modalities on patient survival.

Main Methods:

  • Retrospective analysis of 11 patients with cerebral gliosarcoma treated between 1993 and 2001.
  • Data collected on surgical resection extent, radiotherapy techniques (Cobalt-60, LINAC), and chemotherapy (temozolomide).
  • Comparison of survival rates based on the predominant tumor component (sarcomatous vs. gliomatous) and treatment strategy (single, dual, or multimodal therapy).

Related Experiment Videos

Main Results:

  • Patients with a prevalent sarcomatous component had a significantly longer median survival (71 weeks) compared to those with a prevalent gliomatous component (63 weeks) (P=0.0417).
  • Multimodality therapy (surgery, radiotherapy, and chemotherapy) was associated with longer survival times than single or dual-modality treatments.
  • Total or subtotal surgical resection was achieved in all 10 surgically treated patients.

Conclusions:

  • Gliosarcoma prognosis remains poor, but a multidisciplinary treatment approach appears to offer a survival benefit.
  • The predominant tumor component may influence patient outcomes, with a sarcomatous prevalence potentially linked to better survival.
  • Further research is warranted to optimize treatment strategies for gliosarcoma.